This department is offering the grant to accelerate translational and clinical Phase I and II studies focusing on probiotic/prebiotic components and human microbiome research. The grant aims to substantiate functional benefits and understand the mechanisms of action, as well as variations in responses. Interdisciplinary collaborations are encouraged across various scientific disciplines like microbiology, genomics, immunology, and computational biology. Phase III clinical trials are not supported. Closing date: Sep 07, 2021.
Opportunity ID: 308209
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-18-902 |
| Funding Opportunity Title: | Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 14, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 07, 2021 |
| Current Closing Date for Applications: | Sep 07, 2021 |
| Archive Date: | Oct 13, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Public housing authorities/Indian housing authorities Small businesses Private institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Native American tribal governments (Federally recognized) State governments City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding opportunity announcement (FOA) is twofold: 1. to accelerate translational and clinical Phase I and II a/b safety and efficacy studies for substantiating measurable functional benefits of probiotic/prebiotic components and/or their combinations; and; 2. to understand the underlying mechanisms of their action(s), and variability in responses to these interventions. This FOA calls for interdisciplinary collaborations across scientific disciplines engaged in microbiome and pro/prebiotic research including, but not limited to: nutritional science, microbiology, virology, microecology and microbiome, genomics, immunology, computational biology, chemistry, bioengineering, as well as integration of omics and computational approaches in DNA technologies. This FOA will not support phase III clinical trials. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-18-902.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00244407 | Sep 05, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259070 | Sep 05, 2018 | Sep 07, 2021 | View |
Package 1
Mandatory forms
308209 RR_SF424_2_0-2.0.pdf
308209 PHS398_CoverPageSupplement_4_0-4.0.pdf
308209 RR_OtherProjectInfo_1_4-1.4.pdf
308209 PerformanceSite_2_0-2.0.pdf
308209 RR_KeyPersonExpanded_2_0-2.0.pdf
308209 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
308209 RR_Budget_1_4-1.4.pdf
308209 RR_SubawardBudget30_1_4-1.4.pdf
308209 PHS398_ModularBudget_1_2-1.2.pdf
308209 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
308209 RR_SF424_2_0-2.0.pdf
308209 PHS398_CoverPageSupplement_5_0-5.0.pdf
308209 RR_OtherProjectInfo_1_4-1.4.pdf
308209 PerformanceSite_2_0-2.0.pdf
308209 RR_KeyPersonExpanded_2_0-2.0.pdf
308209 PHS398_ResearchPlan_4_0-4.0.pdf
308209 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
308209 RR_Budget_1_4-1.4.pdf
308209 RR_SubawardBudget30_1_4-1.4.pdf
308209 PHS398_ModularBudget_1_2-1.2.pdf
308209 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
